(Q28209606)

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

The European Brain Injury Consortium survey of head injuries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Unexpected contribution of moderate traumatic brain injury to death after major trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Craniocerebral trauma: protection and retrieval of the neuronal population after injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

A mechanistic analysis of nondisruptive axonal injury: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Selective loss of neurons from the thalamic reticular nucleus following severe human head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Ultra-early evaluation of regional cerebral blood flow in severely head-injured patients using xenon-enhanced computerized tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

The neurochemical and metabolic cascade following brain injury: moving from animal models to man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Focal ischemia due to traumatic contusions documented by stable xenon-CT and ultrastructural studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Factors affecting excitatory amino acid release following severe human head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Gadolinium DTPA enhanced magnetic resonance imaging in acute head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Concussive brain injury is associated with a prolonged accumulation of calcium: a 45Ca autoradiographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Kinetic and pharmacological properties distinguishing three types of calcium currents in chick sensory neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Effects of an N-type calcium channel antagonist (SNX 111; Ziconotide) on calcium-45 accumulation following fluid-percussion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Molecular biology of CNS injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

The role of excitatory amino acids in severe brain trauma: opportunities for therapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Role of excitatory amino acid-mediated ionic fluxes in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Traumatic brain axonal injury produces sustained decline in intracellular free magnesium concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Magnesium sulphate improves neurologic outcome following severe closed head injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Significant reduction in brain swelling by administration of nonpeptide kinin B2 receptor antagonist LF 16-0687Ms after controlled cortical impact injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Post-injury administration of BIBN 99, a selective muscarinic M2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Cerebral hemodynamic effects of phenylephrine and L-arginine after cortical impact injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Experimental brain injury induces expression of interleukin-1β mRNA in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Corticosteroids in head injury. It's time for a large simple randomised trial. CRASH trial management group. Corticosteroid randomisation after significant head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Neuroprotective effects of citicoline on brain edema and blood-brain barrier breakdown after traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Apoptosis: overview and signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

The novel compound LOE 908 attenuates acute neuromotor dysfunction but not cognitive impairment or cortical tissue loss following traumatic brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Transplantation of neural progenitor and stem cells: developmental insights may suggest new therapies for spinal cord and other CNS dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

A trial of the effect of nimodipine on outcome after head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Lack of effect of induction of hypothermia after acute brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Prevention of secondary ischemic insults after severe head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Neuroprotection in cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753

Size and quality of randomised controlled trials in head injury: review of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.753